FONAR Co. (NASDAQ:FONR) Shares Bought by Acuitas Investments LLC

Acuitas Investments LLC raised its stake in FONAR Co. (NASDAQ:FONR) by 142.1% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 113,400 shares of the medical equipment provider’s stock after purchasing an additional 66,563 shares during the quarter. Acuitas Investments LLC owned 1.79% of FONAR worth $1,814,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of FONR. Inspire Advisors LLC acquired a new stake in FONAR in the first quarter valued at about $218,000. Denali Advisors LLC boosted its stake in shares of FONAR by 20.1% in the first quarter. Denali Advisors LLC now owns 16,100 shares of the medical equipment provider’s stock valued at $344,000 after buying an additional 2,700 shares in the last quarter. Linden Thomas Advisory Services LLC grew its holdings in FONAR by 9.6% during the second quarter. Linden Thomas Advisory Services LLC now owns 21,605 shares of the medical equipment provider’s stock worth $346,000 after acquiring an additional 1,900 shares during the period. Empowered Funds LLC raised its position in FONAR by 37.6% in the first quarter. Empowered Funds LLC now owns 16,492 shares of the medical equipment provider’s stock worth $352,000 after acquiring an additional 4,507 shares in the last quarter. Finally, O Shaughnessy Asset Management LLC raised its position in FONAR by 38.9% in the first quarter. O Shaughnessy Asset Management LLC now owns 32,978 shares of the medical equipment provider’s stock worth $704,000 after acquiring an additional 9,237 shares in the last quarter. Institutional investors and hedge funds own 50.64% of the company’s stock.

Analysts Set New Price Targets

Separately, StockNews.com raised FONAR from a “buy” rating to a “strong-buy” rating in a research note on Friday, August 9th.

FONAR Stock Performance

FONAR stock opened at $16.22 on Friday. FONAR Co. has a fifty-two week low of $12.13 and a fifty-two week high of $24.05. The company has a market capitalization of $102.64 million, a price-to-earnings ratio of 10.40 and a beta of 1.19. The stock has a fifty day moving average of $17.11 and a two-hundred day moving average of $17.90.

About FONAR

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.